BioMed Research International

BioMed Research International / 2014 / Article

Research Article | Open Access

Volume 2014 |Article ID 240243 | https://doi.org/10.1155/2014/240243

Kannappan Poornima, Palanisamy Chella Perumal, Velliyur Kanniappan Gopalakrishnan, "Protective Effect of Ethanolic Extract of Tabernaemontana divaricata (L.) R. Br. against DEN and Fe NTA Induced Liver Necrosis in Wistar Albino Rats", BioMed Research International, vol. 2014, Article ID 240243, 9 pages, 2014. https://doi.org/10.1155/2014/240243

Protective Effect of Ethanolic Extract of Tabernaemontana divaricata (L.) R. Br. against DEN and Fe NTA Induced Liver Necrosis in Wistar Albino Rats

Academic Editor: Andrei Surguchov
Received28 Feb 2014
Revised26 Jun 2014
Accepted26 Jun 2014
Published17 Jul 2014

Abstract

This study is an attempt to evaluate the hepatoprotective activity of Tabernaemontana divaricata against DEN and Fe NTA induced liver necrosis in rats. Ethanolic extract of the whole plant of Tabernaemontana divaricata at doses of 200 and 400 mg/kg body weight and 5-fluorouracil (standard drug) was orally administered to male Wistar Albino rats once daily for 24 weeks, simultaneously treated with the carcinogen DEN and Fe NTA. In simultaneously treated animals, the plant extract significantly decreased the levels of uric acid, bilirubin, AST, ALT, and ALP in serum and increased the levels of liver marker enzymes in liver. Treatment with the extracts resulted in a significant increase in the levels of antioxidants accompanied by a marked reduction in the levels of malondialdehyde when compared to DEN and Fe NTA treated group. When compared with 200 mg/kg bw rats, 400 mg/kg bw rats and 5-fluorouracil treated rats showed better results in all the parameters. The histopathological studies confirmed the protective effects of extract against DEN and Fe NTA induced liver necrosis. Thus, it could be concluded that the use of Tabernaemontana divaricata extract in the treatment of carcinogen induced hepatic necrosis.

1. Introduction

Liver is the most important organ, which plays a pivotal role in regulating various physiological processes in the body [1]. It is involved in several vital functions, such as metabolism, secretion, and storage. It has great capacity to detoxicate toxic substances and synthesize useful principles. Therefore, damage to the liver inflicted by hepatotoxic agents is of grave consequences [2].

Oxidative stress, an important factor that induces liver fibrosis, represents a key feature of hepatitis induced by various conditions, including anoxic/reoxygenation injury, autoimmune hepatitis, viral hepatitis, and alcoholic hepatitis [3]. Less severe oxidative stress may sustain fibrosis progression by the activation and morphological change in hepatic stellate cells (HSCs) that include promoting proliferative activity, synthesis, and degradation/remodeling of the extracellular matrix, chemotaxis, contractility, proinflammatory activity, and retinoid loss [4]. Ferric nitrilotriacetic acid (Fe-NTA) and diethyl nitrosamine (DEN) are used extensively to induce oxidative stress and assumed to initiate free radical mediated lipid peroxidation leading to the accumulation of lipid-derived oxidation products that cause liver injury and excess collagen deposition in the liver, resulting in liver necrosis [5]. Conventional or synthetic drugs used in the treatment of liver diseases are sometimes inadequate and can have serious adverse effects [6]. On the other hand, Ayurveda, an indigenous system of medicine in India, has a long tradition of treating liver disorders with plant drugs [7].

Tabernaemontana divaricata (L.) R. Br. is a glabrous, evergreen, dichotomously branched shrub, belonging to the family Apocynaceae. It is a shrub very common in India and grows to a height of 6–8 feet. It is distributed in upper Ganjetic plain, Garhwal, East Bengal, Assam, Karnataka, Kerala, Tamilnadu, and Burma [8]. It has been extensively investigated and rich in a number of chemical constituents such as alkaloids, triterpenoids, steroids, flavanoids, phenylpropanoids, and phenolic acids. In Ayurveda, the root is acrid; bitter with a flavor; digestible; useful in Kapha, biliousness, and diseases of the blood [9]. It is aphrodisiac; tonic especially to the brain, liver, and spleen and it is also a purgative. The milky juice mixed with oil is rubbed on to the head to cure the pain in the eye. The milky juice is very useful in many eye infections, especially red eye. It kills intestinal worms, and its root when chewed relieves tooth ache. Herbal medicines have been proved to be powerful therapeutics for treatment of various human sufferings including cancer, arteriosclerosis, ulcer, diabetes, kidney diseases, and liver diseases [10]. The ethanol and aqueous extracts of Tabernaemontana divaricata (L.) R. Br. flower possess very good in vitro superoxide, hydroxyl and nitric oxide radical scavenging, and lipid peroxidation inhibiting activities [8, 11] The phytochemical screening of the plant extract showed the presence of alkaloids, saponin, tannin, phenolic compounds, flavonoids, cardioglycosides, terpenoid, amino acids, proteins, and carbohydrates [8]. The toxicological evaluation study was already carried out. The plant extract is safe up to 2000 mg/kg body weight. The subacute study also showed no abnormalities in biochemical and marker enzymes of liver and kidney [12]. On the basis of folklore usage and previous research findings, a systematic research was undertaken to evaluate the protective effect of ethanolic extract of Tabernaemontana divaricata (L.) R. Br. against DEN and Fe NTA induced liver necrosis in male Wistar albino rats by in vivo model.

2. Materials and Methods

2.1. Plant Collection and Authentication

The whole plant of Tabernaemontana divaricata (L.) R. Br. was collected in and around Coimbatore district of Tamil Nadu, India, and authenticated by Dr. P. Satyanarayana, Scientist D, Botanical Survey of India, Coimbatore, Tamil Nadu, India. The Voucher number is BSI/SRC/5/23/2011-12/Tech. 1538. The whole plant was cut into pieces, cleaned, air dried at 25°C for 10 days in the absence of sunlight, and powdered well into a coarse powder using a mixer. Then they were weighed and kept in an airtight container and stored in refrigerator for future use.

2.2. Preparation of Extract

50 g of the powdered whole plant material of Tabernaemontana divaricata (L.) R. Br. was extracted by continuous extraction using soxhlet apparatus with the solvent ethanol for 72 hrs. The resultant extract was concentrated to dryness under reduced pressure below 40°C in rotary evaporator and stored at 4°C in a tightly capped brown bottle and kept in refrigerator for the study. According to OECD guidelines, the doses were determined and administered.

2.3. Preparation of Fe NTA Solution

Fe NTA solution was prepared fresh immediately before its use by the method of Awai et al. [13] as modified by Athar and Iqbal [14]. To prepare Fe NTA, ferric nitrate (0.16 mmol/kg body weight) solution was mixed with fourfold molar excess of disodium salt of NTA (0.64 nmol) and the pH was adjusted to 7.4 with sodium bicarbonate solution. The concentration of the Fe NTA solution prepared was 10 mL/kg body weight and the dose was 9 mg Fe/kg body weight.

2.4. Experimental Design
2.4.1. Animals

Adult male Albino rats weighing about 120–140 g were obtained from the animal house of Karpagam Arts and Science College, Coimbatore, India. The animals were maintained under standard conditions and were housed four per cage in polypropylene cages with a wire mesh top and a hygienic bed of husk in a specific pathogen free animal room under controlled conditions of 12 h light and 12 h dark cycle, with temperature of °C and relative humidity of %, and fed with rodent diet and water ad libitum. The study was approved by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Government of India.

2.4.2. Induction of Carcinogen

The carcinogenesis was initiated by a single intraperitoneal injection of DEN (diethyl nitrosamine) at a dose level of 200 mg/kg body weight. After ten days the carcinogenesis is promoted by Fe-NTA at a dose level of 9 mg Fe/kg body weight (ip) twice a week for 24 weeks.

2.4.3. Experimental Protocol

Forty-two albino rats were randomly allocated to seven groups of six rats each.Group I received only normal food and water.Group II received a single intraperitoneal injection of DEN at a dose level of 200 mg/kg body weight in the first day and after ten days the carcinogenesis was promoted by Fe NTA at a dose level of 9 mg Fe/kg body weight (ip) twice a week for twenty-four weeks.Groups III and IV were induced with carcinogen and simultaneously treated with the plant extract (200 and 400 mg/kg bw), respectively, daily for twenty-four weeks.Groups V and VI received only the plant extract (200 and 400 mg/kg bw), respectively, daily for twenty four weeks.Group VII animals were induced with carcinogen and simultaneously treated with the standard drug, 5 fluorouracil (20 mg/kg bw), for twenty-four weeks.

All rats were sacrificed 12 h after the experimental period. Blood was collected and the serum was separated.

2.4.4. Preparation of Tissue Homogenate

Liver was removed quickly and washed in ice cold isotonic saline. The tissue was homogenized in 0.1 M Tris-HCl buffer of pH 7.4 at 4°C in a potter homogenizer, at 600 rpm for 3 minutes. The filtrate was used for further estimations.

2.4.5. Estimation of Biochemical Parameters

Aliquot of the diluted serum was used for the estimation of serum biomarkers like uric acid [15], bilirubin [16], aspartate transaminase (AST) [17], alanine transaminase (ALT) [17], and alkaline phosphatase (ALP) [18] with their respective methods.

2.4.6. Estimation of Liver Marker Enzymes in Liver

Estimation of liver marker enzymes such as aspartate transaminase (AST) [17], alanine transaminase (ALT) [17], alkaline phosphatase (ALP) [18], acid phosphatase (ACP) [19], lactate dehydrogenase (LDH) [20], and 5′ nucleotidase [21] was estimated in the liver tissue homogenate by the respective methods.

2.4.7. Estimation of Lipid Peroxidation

Lipid peroxidation was measured by the thiobarbituric acid (TBA) reaction method [22]. In brief, samples were mixed with TBA reagent consisting of 0.375% TBA and 15% trichloroacetic acid in 0.25-N hydrochloric acid. The reaction mixtures were placed in a boiling water bath for 30 min and centrifuged at 1800 g for 5 min. The absorbance of the supernatant was measured at 535 nm. MDA, a measure of lipid peroxidation, was calculated using an extinction coefficient of 1.56 × 105/M cm. The results were expressed as μM/mg protein.

2.4.8. Antioxidant Assays

The liver homogenate was used to analyze the enzymatic antioxidant activities by superoxide dismutase (SOD) [23], catalase (CAT) [24], glutathione peroxidase (GPx) [25], glutathione-S-transferase (GST), peroxidase (Px) [26], and glucose-6-phosphate dehydrogenase (G6PD) [27], and nonenzymatic antioxidants like reduced glutathione (GSH) [28], total sulphydryl group [29], and vitamin C [30] were evaluated in liver tissue homogenate by respective methods.

2.4.9. Histopathological Studies

For histological studies, the liver tissues were fixed with 10% phosphate buffered neutral formalin, dehydrated in graded (50%–100%) alcohol and embedded in paraffin. Thin sections (5 μm) were cut and stained with routine hematoxylin and eosin (H&E) stain for photo microscopic assessment. The initial examination was qualitative, with the purpose of determining histopathological lesions in liver.

2.5. Statistical Analysis

Results were expressed as mean ± SD. The statistical comparison among the groups was performed with one-way ANOVA test using a statistical package program (SPSS 10.0) at significant level.

3. Results and Discussion

3.1. Estimation of Biochemical Parameters

Table 1 shows the level of uric acid, bilirubin, AST, ALT, and ALP in serum. The levels of uric acid, bilirubin, AST, ALT, and ALP were increased in DEN initiated and Fe NTA promoted group II animals when compared to the control (group I) animals. Increased levels of uric acid and bilirubin were significantly decreased in group III rats treated with 200 mg/kg bw of the ethanolic extract of Tabernaemontana divaricata (L.) R. Br. whereas in groups IV and VII rats treated with 400 mg/kg bw of the plant extract and the standard drug, respectively, the levels were normalized as those of control. Group V and group VI rats were compared with control group I and they showed no significant change.


ParticularsGroup IGroup IIGroup IIIGroup IVGroup VGroup VIGroup VII

Uric acid (mg/dL)1.54 ± 0.01a3.24 ± 0.02b2.2 ± 0.01c1.56 ± 0.01a1.5 ± 0.03d1.39 ± 0.05e1.42 ± 0.08e
Bilirubin (mg/dL)0.9 ± 0.05a2.37 ± 0.06b1.31 ± 0.06c0.86 ± 0.07a0.9 ± 0.05a0.87 ± 0.03a0.85 ± 0.05a
AST (IU/L) 32.85 ± 1.59a101.13 ± 0.86b57.32 ± 1.51c34.39 ± 0.86d32.85 ± 1.12a32.68 ± 0.77a34.03 ± 0.92ad
ALT (IU/L) 68.99 ± 0.49a138.77 ± 2.97b90.59 ± 0.79c69.85 ± 0.24a72.89 ± 1.31d68.69 ± 0.71a73.24 ± 0.48d
ALP (IU/L) 72.94 ± 0.32a254.0 ± 0.45b141.56 ± 0.41c73.65 ± 0.38d72.62 ± 0.41a70.68 ± 0.64a74.1 ± 0.63d

Values are expressed as mean ± SD ( ).
Values not sharing the common superscript differ significantly (DMRT).
3.2. Estimation of Liver Marker Enzymes in Liver

The liver marker enzymes like AST, ALT, ACP, ALP, LDH, and 5′ nucleotidase of both control and experimental groups were shown in Table 2. A significant reduction in the activity of the enzymes AST, ALT, ACP, ALP, LDH, and 5′ nucleotidase in group II of experimental animals was noticed. These marker enzymes were significantly increased in groups III, IV, and VII animals (plant extract and standard drug treated rats). No significant difference has been observed in the plant extract alone treated groups (groups V and VI) and the control group.


ParticularsGroup IGroup IIGroup IIIGroup IVGroup VGroup VIGroup VII

AST77.94 ± 2.48a44.9 ± 1.71b68.47 ± 1.79c72.66 ± 1.77d76.46 ± 1.17a76.71 ± 1.3a75.85 ± 1.1a
ALT36.25 ± 0.37a26.94 ± 0.71b30.17 ± 0.72c35.37 ± 0.94a36.14 ± 0.46a34.82 ± 0.46a33.73 ± 0.73d
ALP12.95 ± 0.49a7.86 ± 0.66b9.93 ± 0.39c12.85 ± 0.34a12.0 ± 0.4a12.32 ± 0.34a12.32 ± 0.57a
ACP9.39 ± 0.1a4.67 ± 0.15b7.51 ± 0.12c9.02 ± 0.07d9.45 ± 0.16a9.32 ± 0.23a9.27 ± 0.15a
LDH86.51 ± 0.76a52.33 ± 0.64b66.28 ± 0.65c83.71 ± 0.94d84.98 ± 0.78e85.58 ± 0.5e85.36 ± 0.88a
5′ nucleotidase8.63 ± 0.04a5.09 ± 0.05b6.4 ± 0.06c8.14 ± 0.07d8.44 ± 0.17a8.53 ± 0.05a8.31 ± 0.06d

Values are expressed as mean ± SD ( ).
Values not sharing the common superscript differ significantly (DMRT).
Units are as follows:
AST, ALT, LDH—nmoles of pyruvate liberated/min/mg protein.
ALP, ACP—nmoles of phenol liberated/min/mg protein.
5′ nucleotidase—nmoles of phosphate liberated/min/mg protein.
3.3. Lipid Peroxidation and Antioxidant Assays
3.3.1. Lipid Peroxidation and Enzymatic Antioxidant Assays

The changes in the lipid peroxidation and enzymatic antioxidants in the liver are illustrated in Table 3. From the table it is found that the level of lipid peroxidation is increased () significantly and a significant reduction () in the activity of antioxidant enzymes were noted in rats intoxicated with DEN and Fe NTA (group II) when compared to control (group I). The decline of antioxidant status partially explains the mechanism of hepatotoxicity and enhanced radical production by DEN and Fe NTA, whereas in groups III, IV and VII rats treated with 200 mg and 400 mg/kg bw of ethanolic extract of Tabernaemontana divaricata (L.) R. Br. and the standard drug 5 fluorouracil, respectively, the level of these parameters was significantly reverted back to near normal level when compared to group II animals. This shows the ability of the plant extract to scavenge the free radicals by enhancing the enzymatic antioxidants thereby reducing the oxidative stress.


ParticularsControl (Group I)DEN + Fe-NTA (Group II)DEN & Fe-NTA + plant extract (200 mg/kg) (Group III)DEN & Fe-NTA + plant extract (400 mg/kg) (Group IV)Plant extract alone (200 mg/kg) (Group V)Plant extract alone (400 mg/kg) (Group VI)DEN & Fe-NTA + Std drug (GroupVII)

Lipid peroxidation in liver1.56 ± 0.06a4.95 ± 0.14b2.56 ± 0.08c1.74 ± 0.09d1.58 ± 0.06a1.54 ± 0.06a1.59 ± 0.06a
SOD11.08 ± 0.46a6.19 ± 0.30b9.96 ± 0.23c10.92 ± 0.54a11.39 ± 0.22a12.62 ± 0.28a10.41 ± 0.42a
Catalase6.01 ± 0.05a3.25 ± 0.26b4.33 ± 0.08c6.04 ± 0.09a5.96 ± 0.07a6.19 ± 0.07a6.03 ± 0.03a
PX40.22 ± 0.59a16.85 ± 0.91b35.64 ± 0.16c39.33 ± 0.65d39.30 ± 0.38d38.94 ± 0.4d39.19 ± 0.34d
GST131.22 ± 2.7a98.08 ± 2.84b112.86 ± 2.62c130.07 ± 0.60a130.66 ± 1.27a132.56 ± 0.65a131.08 ± 1.99a
G6PD13.95 ± 0.11a5.46 ± 0.24b8.67 ± 0.09c13.51 ± 0.4a13.8 ± 0.21a13.88 ± 0.12a13.7 ± 0.18a
GPx43.94 ± 0.34a21.58 ± 0.59b30.64 ± 0.24c45.06 ± 0.59d45.54 ± 0.44d46.59 ± 0.39e46.16 ± 0.7e

Values are expressed as mean ± SD ( ).
Values not sharing the common superscript differ significantly (DMRT).
Units are as follows: SOD—unit/mg protein; CAT—µ moles of H2O2 consumed/min/mg protein;
Px—units/g tissue:
LPO—nmoles of MDA formed/mg protein.
3.3.2. Nonenzymatic Antioxidants

Table 4 exhibits the levels of nonenzymatic antioxidants in liver of control and experimental animals.


ParticularsControl (Group I)DEN + Fe-NTA (Group II)DEN & Fe-NTA + plant extract (200 mg/kg) (Group III) DEN & Fe-NTA + plant extract (400 mg/kg) (Group IV) Plant extract alone (200 mg/kg) (Group V) Plant extract alone (400 mg/kg) (Group VI) DEN & Fe-NTA + Std drug (GroupVII)

GSH21.28 ± 0.45a11.76 ± 0.59b16.26 ± 0.65c19.81 ± 0.14d20.74 ± 0.42a21.34 ± 0.32a20.02 ± 0.34d
TSH6.7 ± 0.07a3.5 ± 0.05b4.46 ± 0.06c6.68 ± 0.06a6.5 ± 0.04a6.56 ± 0.08a6.57 ± 0.08a
Vitamin C3.0 ± 0.1a1.82 ± 0.18b2.8 ± 0.11c3.02 ± 0.12a3.09 ± 0.05a3.13 ± 0.12a2.84 ± 0.11d

Values are expressed as mean ± SD ( ).
Values not sharing the common superscript differ significantly (DMRT).
The units were expressed in µg/mg protein.

From the table it is found that the level of GSH, TSH, and vitamin C was significantly reverted back to near normal level when treated with the plant extracts (200 and 400 mg/kg bw) and the standard drug when compared to group II treated with DEN and Fe NTA.

3.4. Histopathological Studies

Figure 1 shows the histopathology of liver in both control and experimental groups. Group I shows the normal structure of liver. The portal tracts, central veins, hepatocytes of all zones (zones 1, 2, and 3), sinusoids, and Kuppfer cells appear normal. In group II rats treated with DEN and Fe NTA for a period of 24 weeks, the sections studied show that there is patchy hepatocellular necrosis. The portal tract and central veins appeared normal. There is no obvious dysplasia or malignancy. In group III the experimental animals showed a focal mild hepatocellular necrosis in some parts and the rest of the liver tissue is normal. The portal tracts, central veins, and sinusoids appeared normal. This shows that the treatment has some effect and it is moving to the recovery phase and it was confirmed with group IV rats, in which the rats were treated with carcinogen and the plant extract 400 mg/kg body weight showed no evidence of hepatocellular necrosis. The portal tracts, central veins, and sinusoids appeared normal; this shows the effective nature of the extract. In group V and group VI no abnormal changes were seen and the results are similar to those of the control. This shows the safety nature of the plant extract. In standard drug treated group (group VII) the results are similar to those of control. This confirms the safety and effective nature of the ethanolic extract of Tabernaemontana divaricata (L.) R. Br. against DEN and Fe NTA.

4. Discussion

Liver plays a pivotal role in regulation of physiological processes such as metabolism, secretion, and storage. Unfortunately it is a common target for a number of toxicants [31]. An iron chelate, ferric nitrilotriacetate (Fe-NTA), induces necrosis as a consequence of lipid peroxidation and oxidative tissue damage that eventually leads to high incidence of cancer in liver and kidney. Fe-NTA acts through the generation of free radicals and by enhancing the rate of DNA synthesis with simultaneous decrease in antioxidant defenses.

However, unfortunately, the modern system of medicine offers only limited options for its cure. Thus, there is a great necessity for developing alternative strategies to cope with it. Use of safe plant based compounds is one of the most valuable options to prevent and/or delay the neoplastic inception. Consequently, a lot of scientific research is currently focused on exploration of safe and effective phytochemicals for the management of liver necrosis. Plants produce a large number of naturally occurring secondary metabolites, many of which have unique pharmacologic activities [32, 33].

In our present study the ethanolic extract of Tabernaemontana divaricata (L.) R. Br. showed a good hepatoprotective activity against DEN and Fe NTA induced liver necrosis. The increased levels of marker enzyme in serum and decreased level in the liver are indicators of cellular damage and loss of functional integrity of the cell membrane due to DEN and Fe NTA administration. Treatment with the ethanolic extract of Tabernaemontana divaricata (L.) R. Br. brought back these enzymes to near normal level by probably preserving the functional integrity of the hepatocytes showing its hepatoprotective action against DEN and Fe NTA induced liver damage. The present study was in accordance with that of Langaswaran et al. [34].

The ethanolic extract of Tabernaemontana divaricata (L.) R. Br. showed that the increased activity of GST supports the detoxification capacity and the degradation of electrophilic metabolites by this enzyme. Sangeetha and Krishnakumari [35] reported that the decreased activity of hepatic markers in carbon tetrachloride induced toxicity was increased by treatment with Tephrosia purpurea. Gupta et al. [36] reported that the MEBR extract treated animals restored the hepatic lipid peroxidation and free radical scavenging enzyme GSH as well as antioxidant enzymes such as SOD and CAT in tumour bearing mice to near normal levels. In the present study, DEN and Fe NTA induced fall of AST and ALT in liver associated with rise in plasma suggests the extent of liver damage and release of these enzymes from the damaged liver cells and disruption of cellular integrity. The decrease in the liver AST and ALT supports the hypothesis of hepatocellular necrosis. It is also confirmed by histopathological examinations that the abnormalities produced by the carcinogen is reverted back to near normal in plant extract (200 and 400 mg/kg bw) treated groups of rats.

5. Conclusion

To conclude, the plant has a very good antioxidant and hepatoprotective effect against liver cell necrosis induced by DEN and Fe-NTA in male Wistar Albino rats and it can be used for the purpose of hepatoprotection.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgment

The authors are thankful to their Chancellor, Chief Executive Officer, Vice-Chancellor, and Registrar of Karpagam University for providing facilities and encouragement.

References

  1. P. Sharma, S. L. Bodhankar, and P. A. Thakurdesai, “Protective effect of aqueous extract of Feronia elephantum correa leaves on thioacetamide induced liver necrosis in diabetic rats,” Asian Pacific Journal of Tropical Biomedicine, vol. 2, pp. 691–695, 2012. View at: Publisher Site | Google Scholar
  2. S. Mistry, K. R. Dutt, and J. Jena, “Protective effect of Sida cordata leaf extract against CCl4 induced acute liver toxicity in rats,” Asian Pacific Journal of Tropical Medicine, vol. 3, no. 4, pp. 280–284, 2013. View at: Publisher Site | Google Scholar
  3. N. Singh, V. Kamath, K. Narasimhamurthy, and P. S. Rajini, “Protective effect of potato peel extract against carbon tetrachloride-induced liver injury in rats,” Environmental Toxicology and Pharmacology, vol. 26, no. 2, pp. 241–246, 2008. View at: Publisher Site | Google Scholar
  4. S. Sreelatha, P. R. Padma, and M. Umadevi, “Protective effects of Coriandrum sativum extracts on carbon tetrachloride-induced hepatotoxicity in rats,” Food and Chemical Toxicology, vol. 47, no. 4, pp. 702–708, 2009. View at: Publisher Site | Google Scholar
  5. V. Mihailović, M. Mihailović, A. Uskoković et al., “Hepatoprotective effects of Gentiana asclepiadea L. extracts against carbon tetrachloride induced liver injury in rats,” Food and Chemical Toxicology, vol. 52, pp. 83–90, 2013. View at: Publisher Site | Google Scholar
  6. J. Y. Liu, C. C. Chen, W. H. Wang, J. Hsu, M. Yang, and C. Wang, “The protective effects of Hibiscus sabdariffa extract on CCl4-induced liver fibrosis in rats,” Food and Chemical Toxicology, vol. 44, no. 3, pp. 336–343, 2006. View at: Publisher Site | Google Scholar
  7. B. H. Wang, K. A. Zuzel, K. Rahman, and D. Billington, “Protective effects of aged garlic extract against bromobenzene toxicity to precision cut rat liver slices,” Toxicology, vol. 126, no. 3, pp. 213–222, 1998. View at: Publisher Site | Google Scholar
  8. S. Surya, K. Poornima, G. Ravikumar et al., “In vitro antioxidant activity and phytochemical screening of ethanolic extract of Tabernaemontana coronaria (L.),” Pharmacologyonline, vol. 2, pp. 212–218, 2011. View at: Google Scholar
  9. S. Ushasri, C. G. Kumar, M. Sekhar et al., “Preliminary phytochemical and anthelmintic screening of leaves, bark, roots of plant Tabernaemontana coronaria,” International Journal of Research in Ayurveda & Pharmacy, vol. 4, no. 1, pp. 108–111, 2013. View at: Google Scholar
  10. M. S. A. Khan, A. M. Jais, and A. Afreen, “Prostaglandin analogous and antioxidant activity mediated gastroprotective action of Tabernaemontana divaricata (L.) R. Br. flower methanolic extract against chemically induced gastric ulcers in rats,” BioMed Research International, vol. 2013, Article ID 185476, p. 18, 2013. View at: Publisher Site | Google Scholar
  11. P. Thambi, B. Kuzhivelil, M. C. Sabu, and C. I. Jolly, “Antioxidant and anti-inflammatory activities of the flowers of Tabernaemontana coronaria (l) R.BR,” Indian Journal of Pharmaceutical Sciences, vol. 68, no. 3, pp. 352–355, 2006. View at: Publisher Site | Google Scholar
  12. K. Poornima, R. Krishnan, K. V. Aswathi, and V. K. Gopalakrishnan, “Toxicological evaluation of ethanolic extract of Tabernaemontana coronaria (L) R. Br.,” Asian Pacific Journal of Tropical Disease, vol. 2, pp. S679–S684, 2012. View at: Google Scholar
  13. M. Awai, M. Narasaki, Y. Yamanoi, and S. Seno, “Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental hemochromatosis,” The American Journal of Pathology, vol. 95, pp. 663–673, 1979. View at: Google Scholar
  14. M. Athar and M. Iqbal, “Ferric nitrilotriacetate promotes N-diethylnitrosamine-induced renal tumorigenesis in the rat: Implications for the involvement of oxidative stress,” Carcinogenesis, vol. 19, no. 6, pp. 1133–1139, 1998. View at: Publisher Site | Google Scholar
  15. W. T. Caraway, Uric Acid in Standard Methods of Clinical Chemistry, vol. 4, Seligson Academic Press, New York, NY, USA, 1963.
  16. H. T. Malloy and K. A. Evelyn, “The determination of bilirubin with the photoelectric colorimeter,” The Journal of Biological Chemistry, vol. 119, no. 2, pp. 481–490, 1963. View at: Google Scholar
  17. S. Reitman and S. Frankel, “A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases.,” The American journal of clinical pathology, vol. 28, no. 1, pp. 56–63, 1957. View at: Google Scholar
  18. E. J. King and A. R. Armstrong, “Determination of serum and bile phosphatase activity,” Canadian Medical Association Journal, vol. 31, pp. 56–63, 1934. View at: Google Scholar
  19. J. King, “The hydrolases acid and alkaline phosphatase,” in Practical Clinical Enzymology, D. Van, Ed., pp. 191–208, Kerstin Company, London, UK, 1965. View at: Google Scholar
  20. J. King, “The Dehydrogenase or oxido reductase-lactate Dehydrogenase,” in Practical Clinical Enzymology, D. Van, Ed., pp. 83–93, Norstand Company, 1965. View at: Google Scholar
  21. D. M. Campbell, “Determination of 5′ nucleotidase in blood serum,” Biochemistry Journal, vol. 84, p. 34, 1988. View at: Google Scholar
  22. T. R. Berton, C. J. Conti, D. L. Mitchell et al., “The effect of vitamin E acetate on ultraviolet-induced mouse skin carcinogenesis,” Molecular Carcinogen, vol. 23, pp. 175–184, 1998. View at: Google Scholar
  23. S. Das, S. Vasishat, R. Snehlata, N. Das, and L. M. Srivastava, “Correlation between total antioxidant status and lipid peroxidation in hypercholesterolemia,” Current Sciences, vol. 78, pp. 486–487, 2000. View at: Google Scholar
  24. A. K. Sinha, “Colorimetric assay of catalase,” Analytical Biochemistry, vol. 47, no. 2, pp. 389–394, 1972. View at: Publisher Site | Google Scholar
  25. J. T. Rotruck, A. L. Pope, H. E. Ganther, A. B. Swanson, D. G. Hafeman, and W. G. Hoekstra, “Selenium: biochemical role as a component of glatathione peroxidase,” Science, vol. 179, no. 4073, pp. 588–590, 1973. View at: Publisher Site | Google Scholar
  26. U. Reddy, “Antioxidant vitamins in cardiovascular disease prevention,” Report on Short Course on Recent Advances in Vitaminology, Acharya N. G. Ranga Agricultural University, Hyderabad, India, 1998. View at: Google Scholar
  27. D. Balinsky and R. E. Bernstein, “The purification and properties of glucose-6-phosphate dehydrogenase from human erythrocyte,” Biohemistry Biophysics Acta, vol. 67, pp. 313–315, 1963. View at: Google Scholar
  28. M. S. Moron, J. W. Depierre, and B. Mannervik, “Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver,” Biochimica et Biophysica Acta, vol. 582, no. 1, pp. 67–78, 1979. View at: Publisher Site | Google Scholar
  29. J. Sedlak and R. H. Lindsay, “Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent,” Analytical Biochemistry, vol. 25, pp. 192–205, 1968. View at: Publisher Site | Google Scholar
  30. S. T. Omaye, T. P. Turbull, and H. C. Sauberchich, “Selected methods for determination of ascorbic acid in cells, tissues and fluids,” Methods in Enzymology, vol. 6, pp. 3–11, 1979. View at: Google Scholar
  31. S. A. Mayer and A. P. Kulkarni, “Hepatotoxicity,” in Introduction to Biochemical Toxicology, pp. 599–628, John Wiley & Sons, New York, NY, USA, 2001. View at: Google Scholar
  32. T. S. Mohamed Saleem, S. Madhusudhana Chetty, S. Ramkanth, V. S. T. Rajan, K. Mahesh Kumar, and K. Gauthaman, “Hepatoprotective herbs—a review,” International Journal of Research in Pharmaceutical Sciences, vol. 1, no. 1, pp. 1–5, 2010. View at: Publisher Site | Google Scholar
  33. C. Chen, H. Chan, Y. Chu et al., “Antioxidant activity of some plant extracts towards xanthine oxidase, lipoxygenase and tyrosinase,” Molecules, vol. 14, no. 8, pp. 2947–2958, 2009. View at: Publisher Site | Google Scholar
  34. K. Langeswaran, A. J. Jagadeesan, S. Vijayaprakash, and M. P. Balasubramanian, “Hepatoprotective and antioxidant activity of Scopariadulcis Linn, against N-Nitrosodiethylamine (DEN) induced hepatotoxicity in experimental rats,” International Journal of Drug Development and Research, vol. 4, pp. 295–303, 2012. View at: Google Scholar
  35. B. Sangeetha and S. Krishnakumari, “Tephrosia purpurea (Linn.) Pers: a folk medicinal plant ameliorates carbon tetrachloride induced hepatic damage in rats,” International Journal of Pharma and Bio Sciences, vol. 1, no. 2, article 175, 10 pages, 2010. View at: Google Scholar
  36. M. Gupta, U. K. Mazumder, R. S. Kumar, and T. S. Kumar, “Antitumor activity and antioxident role of Bauhinia racemosa against Ehrlich ascites carcinoma in Swiss albino mice,” Acta Pharmacologica Sinica, vol. 25, no. 8, pp. 1070–1076, 2004. View at: Google Scholar

Copyright © 2014 Kannappan Poornima et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views2235
Downloads765
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.